|
2025-01-23 |
2025-01-21 |
V
Vente
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
4 000
-1.3%
9,00
36 000 USD
|
4 000
-1.3%
|
9,00
|
36 000 USD
|
|
|
2024-11-13 |
2024-11-11 |
V
Vente
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
4 000
-1.2%
9,00
36 000 USD
|
4 000
-1.2%
|
9,00
|
36 000 USD
|
|
|
2024-08-09 |
2024-08-07 |
A
Achat
|
Samaha Eli
Actionnaire important
|
999 800
+11.7%
7,80
7 798 440 USD
|
999 800
+11.7%
|
7,80
|
7 798 440 USD
|
|
|
2024-07-12 |
2024-07-10 |
VP
Vente planifiée
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
4 000
-1.2%
9,00
36 000 USD
|
4 000
-1.2%
|
9,00
|
36 000 USD
|
|
|
2024-05-03 |
2024-05-01 |
A
Achat
|
Samaha Eli
Actionnaire important
|
499 324
+6.2%
8,75
4 369 085 USD
|
499 324
+6.2%
|
8,75
|
4 369 085 USD
|
|
|
2024-05-03 |
2024-05-01 |
A
Achat
|
Samaha Eli
Actionnaire important
|
999 800
+14.3%
8,75
8 748 250 USD
|
999 800
+14.3%
|
8,75
|
8 748 250 USD
|
|
|
2024-02-22 |
2024-02-22 |
VP
Vente planifiée
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
1 254
-0.4%
8,71
10 922 USD
|
1 254
-0.4%
|
8,71
|
10 922 USD
|
|
|
2023-11-22 |
2023-11-21 |
VP
Vente planifiée
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
1 378
-0.4%
10,29
14 180 USD
|
1 378
-0.4%
|
10,29
|
14 180 USD
|
|
|
2023-11-16 |
2023-11-14 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 482
-0.7%
10,22
25 366 USD
|
2 482
-0.7%
|
10,22
|
25 366 USD
|
|
|
2023-10-18 |
2023-10-16 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 482
-0.7%
9,03
22 412 USD
|
2 482
-0.7%
|
9,03
|
22 412 USD
|
|
|
2023-09-18 |
2023-09-14 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 482
-0.7%
9,89
24 547 USD
|
2 482
-0.7%
|
9,89
|
24 547 USD
|
|
|
2023-08-24 |
2023-08-22 |
VP
Vente planifiée
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
1 807
-0.5%
9,47
17 112 USD
|
1 807
-0.5%
|
9,47
|
17 112 USD
|
|
|
2023-08-15 |
2023-08-11 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 322
-0.7%
9,99
23 197 USD
|
2 322
-0.7%
|
9,99
|
23 197 USD
|
|
|
2023-07-18 |
2023-07-14 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 322
-0.7%
9,84
22 848 USD
|
2 322
-0.7%
|
9,84
|
22 848 USD
|
|
|
2023-06-16 |
2023-06-14 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 322
-0.7%
10,69
24 822 USD
|
2 322
-0.7%
|
10,69
|
24 822 USD
|
|
|
2023-06-12 |
2023-06-08 |
VP
Vente planifiée
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
1 790
-0.5%
11,13
19 923 USD
|
1 790
-0.5%
|
11,13
|
19 923 USD
|
|
|
2023-05-17 |
2023-05-15 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 322
-0.6%
11,26
26 146 USD
|
2 322
-0.6%
|
11,26
|
26 146 USD
|
|
|
2023-04-18 |
2023-04-14 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 323
-0.6%
11,88
27 597 USD
|
2 323
-0.6%
|
11,88
|
27 597 USD
|
|
|
2023-03-16 |
2023-03-14 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 323
-0.6%
10,32
23 973 USD
|
2 323
-0.6%
|
10,32
|
23 973 USD
|
|
|
2023-03-13 |
2023-03-09 |
V
Vente
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
4 000
-1.1%
10,20
40 800 USD
|
4 000
-1.1%
|
10,20
|
40 800 USD
|
|
|
2023-03-08 |
2023-03-06 |
VP
Vente planifiée
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 323
-0.6%
10,05
23 346 USD
|
2 323
-0.6%
|
10,05
|
23 346 USD
|
|
|
2022-12-16 |
2022-12-14 |
V
Vente
|
Winningham Rick E
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
50 000
-3.6%
11,19
559 500 USD
|
50 000
-3.6%
|
11,19
|
559 500 USD
|
|
|
2022-12-05 |
2022-12-01 |
V
Vente
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Dirigeant
|
2 084
-0.7%
10,73
22 361 USD
|
2 084
-0.7%
|
10,73
|
22 361 USD
|
|
|
2022-11-22 |
2022-11-18 |
V
Vente
|
Hindman Andrew A.
SVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
65 000
-13.7%
11,02
716 242 USD
|
65 000
-13.7%
|
11,02
|
716 242 USD
|
|
|
2022-08-18 |
2022-08-16 |
V
Vente
|
GRAHAM RICHARD A
SVP, DEVELOPMENT
Dirigeant
|
4 906
-1.3%
9,71
47 640 USD
|
4 906
-1.3%
|
9,71
|
47 640 USD
|
|
|
2022-08-11 |
2022-08-09 |
V
Vente
|
GRAHAM RICHARD A
SVP, DEVELOPMENT
Dirigeant
|
15 086
-3.9%
8,79
132 606 USD
|
15 086
-3.9%
|
8,79
|
132 606 USD
|
|
|
2022-05-24 |
2022-05-23 |
VP
Vente planifiée
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
1 081
-0.3%
8,93
9 653 USD
|
1 081
-0.3%
|
8,93
|
9 653 USD
|
|
|
2022-03-02 |
2022-02-28 |
VP
Vente planifiée
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Dirigeant
|
2 356
-0.7%
10,16
23 947 USD
|
2 356
-0.7%
|
10,16
|
23 947 USD
|
|
|
2021-03-11 |
2021-03-09 |
V
Vente
|
WORBOYS PHILIP D
SVP, Research & Transl Science
Dirigeant
|
8 829
-2.5%
20,00
176 580 USD
|
8 829
-2.5%
|
20,00
|
176 580 USD
|
|
|
2020-12-16 |
2020-12-14 |
V
Vente
|
GRAHAM RICHARD A
SVP, Development
Dirigeant
|
7 500
-5.7%
19,47
146 058 USD
|
7 500
-5.7%
|
19,47
|
146 058 USD
|
|
|
2020-12-07 |
2020-12-03 |
V
Vente
|
WORBOYS PHILIP D
SVP, Research & Transl Science
Dirigeant
|
4 246
-1.3%
18,00
76 428 USD
|
4 246
-1.3%
|
18,00
|
76 428 USD
|
|
|
2020-08-24 |
2020-08-21 |
V
Vente
|
HAUMANN BRETT K
Chief Medical Officer
Dirigeant
|
25 000
-8.1%
18,29
457 240 USD
|
25 000
-8.1%
|
18,29
|
457 240 USD
|
|
|
2020-08-24 |
2020-08-20 |
V
Vente
|
WORBOYS PHILIP D
SVP, Research & Transl Science
Dirigeant
|
17 103
-4.9%
18,00
307 854 USD
|
17 103
-4.9%
|
18,00
|
307 854 USD
|
|
|
2019-12-16 |
2019-12-12 |
V
Vente
|
SABESAN VIJAY
SVP, Technical Operations
Dirigeant
|
1 027
-0.7%
21,03
21 598 USD
|
1 027
-0.7%
|
21,03
|
21 598 USD
|
|
|
2019-05-20 |
2019-05-17 |
V
Vente
|
O'Connor Donal
|
2 673
-8.8%
20,19
53 968 USD
|
2 673
-8.8%
|
20,19
|
53 968 USD
|
|
|
2019-05-20 |
2019-05-16 |
V
Vente
|
O'Connor Donal
|
1 327
-4.2%
21,00
27 867 USD
|
1 327
-4.2%
|
21,00
|
27 867 USD
|
|
|
2019-03-06 |
2019-03-05 |
V
Vente
|
HEGDE SHARATHCHANDRA S
SVP, Research
|
5 690
-2.1%
24,50
139 405 USD
|
5 690
-2.1%
|
24,50
|
139 405 USD
|
|
|
2019-03-06 |
2019-03-04 |
V
Vente
|
HEGDE SHARATHCHANDRA S
SVP, Research
|
3 343
-1.2%
25,06
83 764 USD
|
3 343
-1.2%
|
25,06
|
83 764 USD
|
|
|
2018-09-14 |
2018-09-12 |
V
Vente
|
WORBOYS PHILIP D
SVP, Translational Science
Dirigeant
|
6 393
-3.7%
28,50
182 201 USD
|
6 393
-3.7%
|
28,50
|
182 201 USD
|
|
|
2018-08-29 |
2018-08-27 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Dirigeant
|
7 119
-7.8%
27,71
197 282 USD
|
7 119
-7.8%
|
27,71
|
197 282 USD
|
|
|
2018-08-16 |
2018-08-15 |
V
Vente
|
GALA RENEE D
SVP, Chief Financial Officer
Dirigeant
|
1 700
-1.0%
27,43
46 623 USD
|
1 700
-1.0%
|
27,43
|
46 623 USD
|
|
|
2018-08-16 |
2018-08-15 |
V
Vente
|
GALA RENEE D
SVP, Chief Financial Officer
Dirigeant
|
39 839
-18.7%
26,71
1 064 032 USD
|
39 839
-18.7%
|
26,71
|
1 064 032 USD
|
|
|
2018-08-16 |
2018-08-14 |
V
Vente
|
GALA RENEE D
SVP, Chief Financial Officer
Dirigeant
|
2 204
-1.0%
27,74
61 136 USD
|
2 204
-1.0%
|
27,74
|
61 136 USD
|
|
|
2018-08-09 |
2018-08-08 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Dirigeant
|
25 355
-20.5%
27,85
706 182 USD
|
25 355
-20.5%
|
27,85
|
706 182 USD
|
|
|
2018-08-09 |
2018-08-07 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Dirigeant
|
4 127
-3.2%
28,03
115 686 USD
|
4 127
-3.2%
|
28,03
|
115 686 USD
|
|
|
2018-08-09 |
2018-08-07 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Dirigeant
|
1 818
-1.4%
28,99
52 707 USD
|
1 818
-1.4%
|
28,99
|
52 707 USD
|
|
|
2018-06-08 |
2018-06-08 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
3 900
-2.9%
23,66
92 260 USD
|
3 900
-2.9%
|
23,66
|
92 260 USD
|
|
|
2018-06-08 |
2018-06-06 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
10 140
-7.1%
24,09
244 268 USD
|
10 140
-7.1%
|
24,09
|
244 268 USD
|
|
|
2018-05-23 |
2018-05-21 |
A
Achat
|
MALKIEL BURTON G
Administrateur non-exécutif
|
1 000
+1.8%
22,54
22 540 USD
|
1 000
+1.8%
|
22,54
|
22 540 USD
|
|
|
2018-05-22 |
2018-05-18 |
V
Vente
|
GALA RENEE D
SVP, Chief Financial Officer
Dirigeant
|
10 000
-4.1%
24,29
242 877 USD
|
10 000
-4.1%
|
24,29
|
242 877 USD
|
|
|
2017-09-08 |
2017-09-06 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
14 670
-9.8%
30,77
451 350 USD
|
14 670
-9.8%
|
30,77
|
451 350 USD
|
|
|
2017-08-23 |
2017-08-21 |
A
Achat
|
PASQUALONE FRANK
SVP, Chief Comm Ops Officer
|
4 000
+1.9%
26,34
105 359 USD
|
4 000
+1.9%
|
26,34
|
105 359 USD
|
|
|
2017-08-14 |
2017-08-11 |
A
Achat
|
MALKIEL BURTON G
|
15 000
+inf%
24,59
368 816 USD
|
15 000
+inf%
|
24,59
|
368 816 USD
|
|
|
2017-08-14 |
2017-08-11 |
A
Achat
|
MALKIEL BURTON G
|
15 000
+46.1%
24,59
368 855 USD
|
15 000
+46.1%
|
24,59
|
368 855 USD
|
|
|
2017-08-14 |
2017-08-11 |
A
Achat
|
WHITESIDES GEORGE M
|
4 000
+inf%
24,69
98 764 USD
|
4 000
+inf%
|
24,69
|
98 764 USD
|
|
|
2017-08-11 |
2017-08-11 |
A
Achat
|
Fore Henrietta
|
6 000
+33.3%
23,99
143 932 USD
|
6 000
+33.3%
|
23,99
|
143 932 USD
|
|
|
2017-08-11 |
2017-08-11 |
A
Achat
|
Winningham Rick E
Chief Executive Officer
Administrateur exécutif
|
10 000
+1.2%
24,50
245 000 USD
|
10 000
+1.2%
|
24,50
|
245 000 USD
|
|
|
2017-03-08 |
2017-03-07 |
V
Vente
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
|
424
-0.3%
30,80
13 059 USD
|
424
-0.3%
|
30,80
|
13 059 USD
|
|
|
2017-03-08 |
2017-03-06 |
V
Vente
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
|
13 576
-7.6%
31,52
427 916 USD
|
13 576
-7.6%
|
31,52
|
427 916 USD
|
|
|
2017-03-07 |
2017-03-03 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
26 829
-14.2%
31,86
854 772 USD
|
26 829
-14.2%
|
31,86
|
854 772 USD
|
|
|
2016-08-25 |
2016-08-25 |
V
Vente
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
Dirigeant
|
4 491
-2.3%
27,99
125 703 USD
|
4 491
-2.3%
|
27,99
|
125 703 USD
|
|
|
2016-08-22 |
2016-08-22 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Dirigeant
|
37 078
-15.9%
27,16
1 007 038 USD
|
37 078
-15.9%
|
27,16
|
1 007 038 USD
|
|
|
2016-08-23 |
2016-08-19 |
V
Vente
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
Dirigeant
|
9 509
-4.6%
27,97
265 967 USD
|
9 509
-4.6%
|
27,97
|
265 967 USD
|
|
|
2016-08-22 |
2016-08-19 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Dirigeant
|
4 870
-2.0%
28,14
137 042 USD
|
4 870
-2.0%
|
28,14
|
137 042 USD
|
|
|
2016-08-22 |
2016-08-18 |
V
Vente
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Dirigeant
|
7 174
-2.9%
28,55
204 818 USD
|
7 174
-2.9%
|
28,55
|
204 818 USD
|
|
|
2016-03-15 |
2016-03-14 |
A
Achat
|
GLAXOSMITHKLINE PLC
Actionnaire important
|
1 301 015
+15.6%
23 027 965,50
29 959 728 534 983 USD
|
1 301 015
+15.6%
|
23 027 965,50
|
29 959 728 534 983 USD
|
|
|
2015-08-18 |
2015-08-18 |
A
Achat
|
LEE JUNNING
Sr. VP, Technical Operations
Dirigeant
|
9 000
+inf%
12,90
116 100 USD
|
9 000
+inf%
|
12,90
|
116 100 USD
|
|
|
2015-08-18 |
2015-08-18 |
A
Achat
|
MALKIEL BURTON G
Administrateur non-exécutif
|
10 000
+94.6%
12,92
129 200 USD
|
10 000
+94.6%
|
12,92
|
129 200 USD
|
|
|
2015-08-17 |
2015-08-17 |
A
Achat
|
GALA RENEE D
SVP, Chief Financial Officer
Dirigeant
|
5 000
+3.2%
12,16
60 800 USD
|
5 000
+3.2%
|
12,16
|
60 800 USD
|
|
|
2015-08-17 |
2015-08-17 |
A
Achat
|
Winningham Rick E
Chief Executive Officer
Administrateur exécutif
|
16 860
+2.9%
12,13
204 512 USD
|
16 860
+2.9%
|
12,13
|
204 512 USD
|
|
|
2015-08-17 |
2015-08-14 |
A
Achat
|
Winningham Rick E
Chief Executive Officer
Administrateur exécutif
|
63 140
+12.1%
11,79
744 421 USD
|
63 140
+12.1%
|
11,79
|
744 421 USD
|
|
|
2015-08-17 |
2015-08-13 |
A
Achat
|
GALA RENEE D
SVP, Chief Financial Officer
Dirigeant
|
5 000
+3.3%
12,19
60 950 USD
|
5 000
+3.3%
|
12,19
|
60 950 USD
|
|
